Yuhan Corp., a South Korean biopharmaceutical company, said Monday its third-quarter net profit jumped more than 80 percent from a year earlier thanks to the release of its lung cancer treatment in the United States.

Net profit for the July-September…

Yuhan Corp., a South Korean biopharmaceutical company, said Monday its third-quarter net profit jumped more than 80 percent from a year earlier thanks to the release of its lung cancer treatment in the United States.

Net profit for the July-September…